Noncontrast MRI out-of-pocket expenses vary quite a bit depending on geography and population.
Outpatient out-of-pocket costs for knee MRI vary considerably across the country, with lower prices in more populous areas, according to a study published in the Journal of the American College of Radiology.
Researchers from the Mayo Clinic in Rochester, MN, sought to determine the variability in pricing for noncontrast knee MRI, based on geographic location and population.
A total of 122 outpatient centers from 43 localities were included in the study. Nonhospital outpatient radiology centers were randomly chosen in each state’s highest-population locality, based on a list generated from the ACR MRI Accreditation Program database. The areas had to have at least two but no more than three centers for study inclusion. The data were further divided by population brackets: 50,000 to 500,000, 500,000 to 1 million, and more than 1 million.
The researchers, posing as a 21-year-old male college student who needed a noncontrast knee MRI to assess a knee injury sustained while playing football, contacted the centers by phone to determine the lowest, out-of-pocket, bundled cost (technical fee plus professional fee). The median (interquartile range) costs were calculated within each locality and region, including Midwest, Northeast, South, and West regions.
The results showed that costs for the examination ranged from $259 to $2,042 across all centers. For centers within a locality, the difference between the minimum and maximum costs ranged considerably among centers. For centers within a locality, the difference between the minimum and maximum costs among centers ranged from $1,592 to $0; median cost differences between localities ranged from $1,488 to $325.
Median cost geographically:
The researchers concluded that out-of-pocket expenses for outpatient knee MRIs varied considerably, both locally and nationally.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.